Fareston (toremifene) for metastatic breast cancer

    Schering will soon introduce Fareston (toremifene) for metastatic breast cancer.

    It's the first estrogen antagonist to hit the market since Nolvadex (tamoxifen) came out 20 years ago.

    Fareston is structurally very similar to Nolvadex.

Practical advice for a better career, with unlimited access to CE

Pharmacy Technician's Letter includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 120+ CE courses, including the popular CE-in-the-Letter
  • Helpful, in-depth Technician Tutorials
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get a quote